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 Differences in metabolic function between breast cancer (BCa) survivors and sedentary-
healthy controls (HC) were assessed using a maximal cardiopulmonary exercise test (CPET) 
before and after a 16-week community-based exercise training program. Thirty-four BCa survivors 
and 21 HC enrolled at baseline, with 31 and 15 participants completing the intervention, 
respectively. At baseline, respiratory exchange ratio (RER) did not differ between groups. 
However, 3-minute blood lactate (3MBL) trended to be higher in HC (p=0.072). Following 
training, there were no changes in RER or between groups, although all change scores were 
positive. 3MBL trended to increase across training (p=0.075). Regression modeling suggested 
exercise intensity as a quadratic function was the strongest predictor of RER measurements (all 
p<0.001), while training had a small but significant impact (p<0.001). In this preliminary analysis, 
lactate production and carbohydrate reliance may increase in BCa survivors following exercise 
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CHAPTER I: INTRODUCTION 
Introduction 
 Breast cancer (BCa) is the most prevalent non-skin cancer amongst women worldwide with 
over 2 million new cases and 600,000 BCa-related deaths in 2018 alone (Bray et al., 2018). The 
overwhelming global presence of this disease strongly advocates for continued investigation into 
the pathology, treatment, and subsequent rehab for survivorship. The evidence examining 
pathology and treatment of BCa is extensive and well-rounded, whereas the literature surrounding 
post-treatment implications is still developing. One emerging facet of survivorship research is the 
investigation of minimizing post-treatment side effects through the implementation of exercise 
training. Many of the more apparent side effects, such as fatigue, underperformance of functional 
tasks, and lowered quality of life (QoL) have current, evidence-based exercise prescription 
guidelines to help BCa survivors reduce symptoms (Campbell et al., 2019; Hayes, Newton, 
Spence, & Galvão, 2019). However, a side effect less investigated but arguably of equal 
importance is metabolic dysfunction, where BCa treatment has been shown to alter carbohydrate 
(CHO), lipid, and lactate metabolism (Edmonson, 1966; Evans, Battaglini, Groff, & Hackney, 
2009; Glicksman & Rawson, 1956; Tosti, Hackney, Battaglini, Evans, & Groff, 2011). Alteration 
of metabolic function in BCa survivors could increase levels of fatigue and stress, further 
impacting the ability to complete activities of daily living (ADLs). A possible solution is to 
examine if acute and chronic exercise can be used to normalize substrate utilization following BCa 
treatment. 
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 At present, there are numerous personalized treatment options available that are dependent 
on the progression, location, and microbiome associated with BCa (Waks & Winer, 2019), ranging 
from surgeries, chemotherapies, and radiation therapies, or a combination of these treatments. Due 
to early detection technologies, different and more efficacious treatment options, and a rapidly 
improving and more comprehensive understanding of BCa pathology, the 5-year survival rate for 
BCa across all stages has improved to ~90%, far higher than most other forms of cancer (Siegel, 
Miller, & Jemal, 2020). Although this is promising for BCa survivors, such a high survival rate 
leaves the survivors potentially suffering from the detrimental side effects years after completion 
of major anti-cancer treatments.   
 Upon diagnosis, a BCa patient is classified as a ‘survivor’. For discussion purposes, it is 
important to distinguish between the subtypes of survivors within the BCa community. The first 
group consists of survivors diagnosed but still on primary treatment, whilst the second group 
consists of survivors post-treatment who could still be living with the lasting impacts of BCa. For 
the latter group, the list of potential side effects can be prolonged and disconcerting. Altered 
metabolic function, fatigue, inability to perform ADLs, and dysfunctional bone and heart health 
(Edmonson, 1966; Glicksman & Rawson, 1956; Guinan et al., 2014; Guinan, Connolly, Kennedy, 
& Hussey, 2013; Odle, 2014) are among side-effects that negatively impact a survivor’s health 
and well-being. Although there are medical approaches for limiting the side effects of cancer 
treatment, these approaches are often based on the use of pharmaceuticals and additional surgeries 
that come with their own harmful side effects (Shapiro & Recht, 2001). As such, alternative 
approaches that mitigate many of the previously mentioned side effects without the additional 
effect of pharmacological treatments or supplemental surgeries are highly desirable.  
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 One strategy that has gained traction in recent years is using exercise to improve or mitigate 
cancer treatment-related side effects whilst promoting better overall health and QoL (Furmaniak, 
Menig, & Markes, 2016). Although this is a relatively new field of study, exercise oncology is 
rapidly evolving with multiple organizations compiling exercise research to guide cancer survivors 
regular participation in exercise (Campbell et al., 2019; Hayes et al., 2019). Currently, the 
prescriptions provide overall recommendations for both aerobic exercise training (AET) and 
resistance training (RT) that are recommended to improve many treatment-related side effects, 
overall health, and QoL of survivors. However, the use of AET and RT to aid dysfunctional 
bioenergetics is still absent from the current guidelines due to insufficient evidence.  
 At present, the current data on substrate utilization at rest and during acute, steady-state 
exercise in BCa survivors is limited. Preliminary work in soft tissue cancer suggests treatment-
induced increases in fat metabolism and attenuated CHO metabolism occur simultaneously within 
survivors at rest (Edmonson, 1966; Glicksman & Rawson, 1956). This metabolic dysfunction at 
rest also persists during acute exercise, with BCa survivors demonstrating diminished CHO usage 
and lowered blood lactate (BL) production compared to healthy women during moderate to high 
intensity, steady state, acute exercise (Evans et al., 2009; Tosti et al., 2011). However, there is 
clarity needed regarding studies focused on reduced BL production during steady state exercise. 
Though different exercise modalities were implemented, it is suggested that decreased BL 
responses between BCa survivors and healthy women occur as low as 40% of oxygen uptake (VO2) 
peak (Tosti et al., 2011), whilst other findings demonstrated it only occurs at higher intensities 
(70% VO2 peak) (Evans et al., 2009). These contradictory findings require further investigation to 
improve our understanding of CHO usage in BCa survivors. Currently, there is little evidence to 
discuss how BCa survivors respond to a variable exercise bout, such as a graded exercise test. 
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Consequently, it is unknown whether the responses seen during steady state bouts will correspond 
to those seen during incremental, acute exercise. A graded-exercise test may be a practical 
approach for future studies, due to its structure of combining multiple intensities into one exercise 
bout and its ability to target CHO as the main substrate source. Additionally, the use of a slow 
increment, ramp-protocol has been proposed as a reliable exercise test for application of steady 
state exercise prescription (Iannetta, De Almeida Azevedo, Keir, & Murias, 2019).  
 Moving beyond acute exercise, the impact of chronic exercise on BCa metabolism is 
unknown and represents another large gap within the field. In healthy individuals, chronic exercise 
improves substrate utilization through greater reliance on lipids at higher intensities, a 
phenomenon known as the cross-over point (Brooks & Mercier, 1994). However, the extent by 
which substrate utilization is altered in BCa survivors following training has not been investigated. 
The additional analysis of BL concentration, an important indicator of bioenergetics efficiency 
during exercise, could provide potential insight into how effectively different metabolic pathways 
are interrelating post-exercise training in cancer survivors (Gladden, 2004). This concept is crucial 
to investigate because without efficient bioenergetics, increased fatigue and stress may hinder 
performance of ADLs, impacting a survivors’ overall QoL.   
Purpose 
  The purpose of this study was to assess the differences in substrate utilization between BCa 
survivors and sedentary-healthy controls (HC) at varying intensities of exercise during a maximal 
cardiopulmonary exercise test (CPET). Additionally, the study aimed to investigate whether a 
community-based exercise program can mitigate the metabolic differences commonly seen 
between BCa survivors and HCs throughout a 16-week combined AET and RT exercise 
prescription. Lastly, the study took into account potential mechanisms and aerobic versus 
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anaerobic relationships that may influence the metabolic changes that could occur over the 16-
week training program.  
Research Questions 
• Objective 1 - During non-steady state, acute exercise, are there differences in substrate 
utilization and lactate production between untrained BCa survivors and HC? 
• Objective 2 – Is the response to acute exercise for substrate utilization and lactate 
production between BCa survivors and HC different following 16 weeks of exercise 
training?  
• Objective 3 – Observationally, is there an increase in the relationship of carbon dioxide 
production (VCO2) and VO2 before and after reaching ventilatory threshold (VT)? 
Research Hypotheses 
Objective 1 – Confirmatory Aim 
Hypotheses in objective 1 served the purpose of validating previous research conducted on BCa 
survivors using the same parameters below, but under slightly different exercise modality and 
testing conditions (Evans et al., 2009; Tosti et al., 2011). Based on prior literature, the following 
directionality was applied to the following hypotheses: 
• Hypothesis 1a: Compared to HC, respiratory exchange ratio (RER) at 40, 60, and 70% of 
peak power output (PPO) will be lower in BCa survivors prior to training.   
• Hypothesis 1b: Compared to HC, post CPET lactate measures will be lower in BCa 
survivors prior to training.  
• Hypothesis 1c. Compared to HC, RER will remain lower in BCa at increasing percentages 
of PPO throughout the duration of the CPET.  
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Objective 2 – Primary Aim 
Hypotheses in objective 2 were rationalized under the assumption that HC participants are not 
currently exhibiting metabolic dysfunction as a result of non-cancer mechanisms. If metabolism is 
functioning as expected in HC, then BCa survivors would see larger improvements in carbohydrate 
metabolism during maximal efforts, due to the improved efficiency of glycolytic pathways (Brooks 
& Mercier, 1994). Based on this evidence, directionality was applied to the following hypotheses: 
• Hypothesis 2a: Compared to HC, change scores (POST-PRE) in RER at 40, 60 and 70% 
of PPO will be larger in BCa survivors following completion of a combined training 
program.   
• Hypothesis 2b: Post CPET lactate measures will be the same between BCa survivors and 
HC following completion of a combined training program. 
• Hypothesis 2c. Compared to baseline, RER will be lower at increasing percentages of PPO 
for BCa survivors and HC controls following completion of a combined training program.   
Objective 3 – Exploratory Aim 
 The exploratory aim investigated the relationship of VCO2 and VO2 before and after VT. 
Based on the theory that ventilation (VE) and VCO2 increase faster than VO2 following the VT 
(Hollmann, 2001; Mezzani, 2017; D. A. Schneider, Phillips, & Stoffolano, 1993), RER should also 
increase rapidly following VT. This shift in RER increase should demonstrate a change in slope 
before and after VT. If BCa survivors exhibit a change from linearity following VT, this may 
propose more normal metabolic function as opposed to remaining linear throughout the entirety of 
the CPET.   
Assumptions 
• Participants followed pre-assessment guidelines 
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• Participants gave their best effort for all exercises performed 
• Participants maintained normal behavior and exercise habits outside of Get Real and Heel 
(GRH) 
Delimitations 
• Sample was all non-metastatic BCa survivors, within 1-year post-treatment 
• All participants were able to perform the majority of the exercises during the intervention 
Limitations 
• Data was analyzed retrospectively 
• RER values were not obtained during non-steady state periods 
• VO2 values were most likely peaks as opposed to true maxes 
• Continuation of hormone therapy was not controlled for 
Significance of Study 
 This study is distinctive because, to our knowledge, a few laboratories have attempted to 
specifically investigate metabolic dysfunction in BCa survivors through implementation of a 
chronic exercise training. There is an immense amount of literature covering the impacts of 
training programs on various other side effects, perhaps due to a feasibility in quantifying 
improvements of certain measurements and elaborating on potential mechanistic changes. 
Substrate utilization is a complex and multi-faceted process that is difficult to study. For these 
reasons, it is difficult to speculate on the causes of changes in CHO, lipid, and lactate metabolism 
observed in BCa survivors. However, there is a need to improve these parameters within BCa 
survivors due to the interconnectedness of QoL and improved performance of ADLs, two of the 
main categories exercise oncologists aim to improve in cancer survivors. Additionally, this study 
could contribute towards the research used to generate American College of Sports Medicine 
 8 
(ACSM) guidelines for exercise prescription. The omittance of metabolic function in the current 
guidelines suggests that additional research is required in order to make an educated consensus 
about the literature and provide appropriate instruction. The use of a community-based training 
program such as GRH will further provide the ecological validity needed to potentially consider 








CHAPTER II: REVIEW OF LITERATURE 
Section 1: Breast Cancer Pathology 
 BCa diagnoses affected over 2 million females worldwide in the last year alone, making it 
the most commonly occurring cancer in women (Bray et al., 2018). More specifically, this disease 
has the potential to impact 1-in-8 women currently residing in the United States, or 12.5% of the 
female population (Siegel et al., 2020). This percentage accounts for roughly 21 million women 
across the country. The disease is so prevalent due to its effectiveness in carcinogenesis. This 
process is defined as continual unregulated proliferation of mutated cells (Hanahan & Weinberg, 
2011). In other words, as a cancerous cell develops within the breast tissue, the mutations alter the 
molecular composition of the cell and prevent the process of regulation during replication. This 
leads to more and more cancerous cells that continue to replicate at a rapid pace. There are several 
“hallmarks of cancer” such as genetic instability, increased proliferative signaling, and cell death 
resistance, that enable oncogenic cell replication (Hanahan & Weinberg, 2011). All of these 
hallmarks tend to play a role in tumor development and growth.  
Section 2: The Process and Consequences of Breast Cancer Treatment 
Process of Treatment 
 Upon diagnosis of cancer, several potential anti-cancer therapies may be used, including 
chemotherapy, radiation therapy, and/or surgery. The optimal treatment approach for BCa patients 
is largely dependent on the phenotype of steroid-associated receptors found within breast tissue 
(Waks & Winer, 2019). These receptors are responsible for binding to estrogen or progesterone, 
two hormones that are essential for female development and reproduction. The 3 main subtypes of 
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BCa are based upon the presence or absence of these receptors, and thus treatment is prescribed 
through determining the composition of receptors (Waks & Winer, 2019). For non-metastatic BCa 
patients, the main purpose of treatment is to remove the tumor and prevent recurrent cancer that 
could become metastatic (Waks & Winer, 2019). This treatment can be provided in the form of 
chemotherapy, radiation therapy, surgery, or any combination thereof. Due to the effectiveness of 
current cancer treatment plans, the 5-year survival rate for this disease is approximately 90% and 
continues to increase annually (Siegel et al., 2020). However, as survival rates increase, the amount 
of BCa survivors that demonstrate deleterious therapy-induced side effects also increases.  
Side Effects 
 The side effects that accompany BCa treatment can be both long-term and potentially fatal. 
There are a few that warrant further in-depth discussion due to their impacts on a survivor’s 
lifestyle. Side effects such as metabolic dysfunction, limited physical function, and heart and bone 
health may be hindering a survivor’s ability to regain their level of QoL established prior to BCa 
diagnosis.  
 For years, it has been known that metabolic dysfunction exists within cancer patients 
following treatment. As early as the 1950’s, a group of mixed cancer patients following treatment 
showed slower glucose uptake, leading to a hyperglycemic state relative to healthy individuals 
(Glicksman & Rawson, 1956). Additionally, ~44% of soft tissue cancer patients presented 
diabetic-glucose curves, suggesting hyperglycemic responses could be linked to the type of cancer 
presented. In the subsequent decade, Edmonson (Edmonson, 1966) took the research one step 
further, including fatty acid mobilization as part of their investigation. Their results suggested that 
due to decreased glucose tolerance, cancer patients may rely more heavily on fatty acid 
mobilization and uptake during a fasted state when compared to controls. However, because both 
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of these studies encompass multiple soft tissue cancer populations it is difficult to elucidate on the 
potential mechanisms caused by a neoplasm. Two more recent studies have isolated BCa as an 
inclusion criterion, focusing on the development of metabolic syndrome (MetSyn) and its 
relationship with energy flux (Guinan et al., 2014, 2013). The aim was to characterize patients into 
different metabolic profiles based on insulin resistance and central obesity, two major indicators 
of metabolic function. As expected, the survivors who were both insulin resistant and obese had 
the greatest dysfunction within the metabolic responses, whereas those who were neither insulin 
resistant or obese most closely resembled lean controls. However, due to the extremely sedentary 
behavior of the sample population, it is difficult to suggest whether the metabolic dysfunction is 
completely dependent on cancer-related side effects or a lack of physical activity (PA) (Guinan et 
al., 2013). The same group then followed up this research with a longitudinal study focused on the 
development of MetSyn at diagnosis compared to post-treatment (Guinan et al., 2014). Their 
results demonstrated significant deleterious impacts on metabolic function over time. Additionally, 
the percentage of patients that were presenting MetSyn at the beginning of treatment increased 
when analyzed post-treatment (Guinan et al., 2014). It is unclear as to whether these increases in 
MetSyn are due to the prolonged administration of anti-cancer treatment, the tumor itself, or other 
habitual factors such as lack of PA.  
 Limited physical function can serve as a compounding side effect that not only reduces a 
survivor’s QoL, but also could exacerbate other issues such as dysfunctional bioenergetics and 
bone health. Limited physical function can arise from various issues such as lymphedema, fatigue, 
or dietary issues, all of which are linked to a lower QoL (Bodai & Tuso, 2015). These underlying 
issues that restrict survivors from performing their ADLs can have big implications for how they 
perceive their current standard of health. The converse argument could be made, as well, 
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suggesting that metabolic dysfunction may make functional tasks more difficult due to inefficient 
metabolic processes, making the mechanism of this side effect a conundrum to understand.  
 Following treatment it is has been shown that BCa survivors are more likely to develop 
cardiovascular disease (CVD), which may be leading to an unintended increase in the number of 
women dying every year from CVD (Bodai & Tuso, 2015). This increase is even more apparent 
in women aged 35-44, as more pre-menopausal women are being diagnosed with BCa. Since CVD 
is the leading cause of death for women in the United States, the added risk for BCa survivors 
makes this side effect one of the most detrimental that will be discussed. In fact, the risk of dying 
from CVD far exceeds the risk of dying from recurrent cancer (Bodai & Tuso, 2015). There are 
two key relationships in which CVD may impact metabolic function. The reliance of metabolic 
processes on CV function is undeniable, suggesting that any complications in CV performance 
and the delivery of oxygen could potentially exacerbate metabolic dysfunction when presented in 
an individual. Additionally, as metabolic inefficiency rises in BCa survivors, the cardiovascular 
system in turn will be required to work harder, putting greater strain on the CV system and causing 
higher risk to the BCa survivor.       
 All of these side effects combined may lead to an overall feeling of distress. Distress is the 
hardest side effect to quantify due to its categorization being based upon a continuum rather than 
an objective measurement (Dizon, 2009). This feeling of distress can easily translate into a 
survivor’s day-to-day lifestyle, having big impacts on their happiness and satisfaction.  
 Often primary cancer treatment, although overwhelming and stressful for the individual, 
last days to months and the tumor is dealt with quickly. It is the lasting side effects that continue 
to impact their QoL for years following treatment which have the largest impact on a survivor. 
With all the side effects previously mentioned, adjunctive therapy is prescribed that often involves 
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mitigation techniques that require additional surgeries or drug treatments. Alternatively, exercise 
has the potential to serve as an equally effective approach to these traditional mitigation 
techniques.   
Section 3: Exercise as Post-Therapy Treatment  
Known Aerobic Training Impacts 
 In order to counteract the side effects that arise due to cancer therapy, a multitude of studies 
have been conducted to investigate the use of exercise as a mitigation tool. Unfortunately, the 
concentrations amongst these studies is uneven, heavily favoring aerobic exercise training (AET) 
and just more recently investigating resistance training (RT) (Galvão & Newton, 2005). A 
systematic review showed that cardiovascular training has been shown to improve aerobic capacity 
and decrease fatigue, leading to a higher QoL (Galvão & Newton, 2005; Kim, Choi, & Jeong, 
2013). This increase is supported primarily through objective measurement of VO2 peak, assessed 
via gold standard CPETs. Increased aerobic capacity from exercise intervention approaches has 
also been shown to limit the risk of CVD, one of the deadliest side effects that derives from the 
use of certain cancer pharmaceuticals, such as anthracycline-based treatments (Galvão & Newton, 
2005).  
 Aerobic exercise has also been shown to improve physical functioning in BCa survivors, 
allowing for easier completion of ADLs. Mock et al. (Mock et al., 1997) demonstrated 
improvements in the ability of BCa survivors, recovering from radiation therapy, to complete 
functional tasks following a walking-pace AET intervention. This is significant because low-to-
moderate intensities of AET are lower than the current recommended ACSM guidelines but the 
outcomes still support beneficial effects of exercise for BCa survivors. In 3 more AET intervention 
studies, analyses of physical functioning and well-being subscales taken from a QoL questionnaire 
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reported large improvements (d=0.84) following exercise treatment (McNeely et al., 2006). It is 
important for this population to not only improve physiologically, but to also report mental improvements 
that suggest survivors believe they are stronger and better equipped for completing ADLs. The 
psychological aspect of QoL can be argued as equally important.  
 Severe and continual anxiety or stress, known as distress, is one of the major psychological side 
effects that results from BCa treatment. This hormonal reaction can be a response to a variety of inducers, 
but there is potential to limit the reaction through aerobic exercise. Following a 10-week program of 
cardiovascular activity at 60% max heart rate (MHR), participants demonstrated lower anxiety and 
depression levels when compared to controls (Galvão & Newton, 2005). The study did not control for 
cause of distress, which suggests that the benefits of exercise intervention are not dependent on 
the inducer of the psychological side effects.   
Known Resistance Training Impacts 
 For most studies conducted using RT, it is often combined with AET to observe impacts 
on fitness, QoL, and body composition. 2 studies incorporated resistance exercises using an 
unspecified intensity and a narrow range of repetitions for each exercise. The results demonstrated 
improvements in both physical function and muscular strength, along with an increase in one QoL 
parameter regarding a participant’s ability to complete daily activities (Galvão & Newton, 2005; 
C. M. Schneider, Hsieh, Sprod, Carter, & Hayward, 2007). Although analysis of aerobic capacity 
through CPETs was not possible, Battaglini et al. (Battaglini et al., 2014) did report that RT also 
has a positive impact on 12-minute walk tests in exercise groups compared to controls (Battaglini 
et al., 2014). Additionally, the literature surrounding RT impacts on body composition supported 
an increase in lean body mass and muscular strength in BCa survivors (Battaglini et al., 2014; Kim 
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et al., 2013). Along with body composition improvements, RT can also improve psychological 
factors such as depression and overall QoL (C. M. Schneider et al., 2007).  
Lack of Evidence on Metabolic Dysfunction 
 The increasing amount of research dedicated to aerobic and resistance training in BCa 
survivors continues to grow each decade. It appears that due to the abundance of investigation into 
AET, more precise exercise prescription has led to even larger improvements and mitigation of the 
previously described side effects (Battaglini et al., 2014). Aforementioned, metabolic dysfunction 
seems to be a side effect that has yet to factored into exercise prescription for BCa survivors. It is 
known that survivors exhibit dysfunction at moderate to high intensities during acute, steady state 
bouts. This understanding comes from a combination of 2 studies, both focused on analyzing 
exercise bouts conducted at 40%, 60%, and 70% of predicted VO2 max for 9 minutes of work on 
a treadmill and cycle ergometer, respectively (Evans et al., 2009; Tosti et al., 2011). In a 
preliminary study using heart rate (HR), rating of perceived exertion (RPE), and BL measures, 
Evans et al. (Evans et al., 2009), suggested that HR and RPE did not differ between BCa and HC 
at any intensity. However, BL was significantly different at 70%. Tosti et al. (Tosti et al., 2011) 
presented results that compounded the findings above. The group analyze RER and BL using the 
same methodology of 40%, 60%, and 70% of VO2 peak for 9-minute, steady state bouts. The BCa 
participants elicited lower lactate production at each intensity compared to the controls, 
contradictory of Evans et al. (Evans et al., 2009) findings of BL differences only at 70% of VO2 
peak. Although, the modalities used during each study were a treadmill and cycle ergometer, a 
change in protocol that may influence the BL outcomes. Additionally, Tosti et al. (Tosti et al., 
2011) demonstrated at all exercise intensities that BCa had lower oxidation rates of CHOs and 
higher oxidation rates of fats compared to matched, HC. Due to the discrepancies between these 
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two findings, further investigation of lactate responses is warranted. Neither study attempted to 
use a higher intensity than 70%, most likely due to a participant’s inability to remain in steady 
state beyond 70% of VO2 peak. To the best of our knowledge, there have been no studies that focus 
on metabolic dysfunction during the predominantly anaerobic state of vigorous intensity exercise 
in BCa survivors. Additionally, these studies differ from many of the reviews and studies described 
due to the lack of training intervention implementation. It is currently unknown how a training 
intervention may impact RER and BL in BCa patients. 
 However, chronic training has been demonstrated to positively impact the metabolic 
processes of healthy individuals. A seminal finding from Brooks & Mercier (Brooks & Mercier, 
1994) proposed the ‘cross-over’ concept. This concept suggests that chronic AET allows for 
greater reliance on lipid oxidation at the same intensity as prior to training. Therefore, glycogen 
stores can be spared for use at higher intensity. Additionally, lactate may serve as a good indicator 
for determining reliance on anaerobic pathways at higher intensity exercise (Gladden, 2004). By 
combining these two impacts in healthy individuals, it can be extrapolated that perhaps chronic 
training has the potential to benefit BCa survivors’ metabolic dysfunction seen at varying 
intensities of exercise.  
Section 4: Exercise in Community-Based Cancer Survivorship Programs 
 Both aerobic and resistance training-based survivorship programs have been implemented 
worldwide to try and promote exercise in cancer survivors. Although there are benefits to 1-on-1 
personal training, there is a trend towards more community-based programs that incorporate group 
activity, such as group aerobics or resistance training. A comparison between home-based and 
community-based programs presents larger effect sizes for physiological and psychological 
outcomes in participants completing group-based activity as opposed to individual training 
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sessions (Swartz et al., 2017). The effectiveness of group training is further supported by the 
Young Men’s Christian Association (YMCA) survivorship program. Initial analysis in 2012 of 
YMCA-associated programs reported physiological improvements in muscular strength, 
functional task completion, and a reduction in fatigue. Additionally, psychological improvements 
were demonstrated through greater scores on QoL questionnaires (Rajotte et al., 2012). The overall 
effectiveness and safety of the YMCA programs established a reputable foundation for continuing 
community-based exercise. Another research group found that community-based programs can 
produce similar QoL improvements in African-American survivors (Nock et al., 2015). This result 
suggests that a communal setting is appropriate for all races, with no socio-demographic 
restrictions that may hinder outcomes. However, the exercise prescription within these programs 
tended to be vague and comprehensive. Although multimodal exercise programs were able to 
produce improvements in functional task completion, muscular strength, flexibility, and balance, 
it is difficult to identify which form of exercise pre-dominantly contributes to improvement (Foley 
& Hasson, 2016). GRH, a community-based cancer survivorship exercise program has previously 
demonstrated clinical improvements in fitness, physical functioning, and QoL (Amatuli, 2020; 
Lee, 2020). The use of a combined training regimen (Table 1) has allowed for a well-rounded 
exercise prescription meeting the requirements set forward by ACSM (Campbell et al., 2019). 
Based on the prior success of GRH and additional support for community-based programs, it can 
be suggested that small-group workouts are an acceptable approach for eliciting metabolic 
improvements in BCa survivors. 
Section 5: Potential Mechanisms for Improved Metabolic Function Following Exercise 
 With a topic such as cancer, it is difficult to elucidate on the potential mechanisms that may 
be responsible for the findings. Cancer is a multi-faceted pathology and improvements on 
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metabolic function could be from many factors such as i) improved insulin resistance, ii) reversal 
of the Warburg Effect iii) and rightward shift of the cross-over point.  
 One option that could result from chronic exercise is improved insulin resistance. It is 
known that insulin resistance improves from exercise due to contraction-induced GLUT4 
translocation. The movement of GLUT4, a glucose uptake transporter, from the intercellular space 
to membrane-bound positions allows for better uptake of glucose into the cell. Although this 
process is independent of insulin, post-exercise insulin sensitivity is increased as a consequence of 
this mechanism (Richter & Hargreaves, 2013). Improved insulin efficiency would in turn lower 
the excessive insulin output reported by Guinan et al. (Guinan et al., 2014) that occurs in order to 
maintain glucose homeostasis.  
 A second potential mechanism could be the reversal of the Warburg Effect. This effect 
occurs during the cancer pathology itself, with the tumor relying upon glucose and lactate as a fuel 
source for replication purposes (Gentric, Mieulet, & Mechta-Grigoriou, 2017). Because of the 
heavy dependance on endogenous substrates for tumorigenesis, it can be suggested that the body 
must find a way to depend less on glucose and lactate for other, healthy processes. This action 
would serve as a defense mechanism, attempting to reduce the amount of glucose and lactate in 
circulation for oncogenic purposes. However, once the tumor is treated, this shunted glucose 
metabolism seems to remain. It is unknown if chronic exercise can mitigate the Warburg Effect 
and return metabolism to a more functional state.  
 The last mechanism proposed is based on research regarding the cross-over concept in 
healthy individuals (Brooks & Mercier, 1994). It could be argued that by taking a fairly sedentary 
group of individuals, as proposed in this study, and implementing a chronic training program, 
scientists would expect to see improvements in metabolism due to training adaptations such as 
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increased mitochondrial density, capillary density, and blood volume that would very likely occur 
in any healthy population (Rivera-Brown & Frontera, 2012). However, this argument may not 
transition directly to BCa survivors due to their altered metabolism prior to entering a training 
program. Improvements in metabolic dysfunction could stem from any or all of these mechanisms, 
making it difficult to discern between them.  
Section 6: Statistical Rationale for Approaching Metabolic Data Averaging & Analysis 
 Within the collected data from this retrospective study, the only consistent variable that 
resides across every single CPET recorded is the incremental increase in wattage. To 
retrospectively estimate 40%, 60%, and 70% of VO2 peak, an appropriate approach is to use 40, 
60, and 70% of PPO. It has previously been established that the relationship between VO2 and 
wattage during steady state exercise is linear up until lactate threshold (LT), at which point VO2 
tends to increase faster than wattage (Zoladz, Rademaker, & Sargeant, 1995). However, it is 
important to take into consideration that at 0 watts, the participant physiologically cannot be at 0 
ml/kg/min for VO2. Because of this difference, % of PPO may be a slight underestimation for 
comparison to percentages of VO2 peak. Although, the important objectives are intra-study group 
comparisons and then inter-study group differences, meaning the raw values from % VO2 studies 
and % PPO will not be directly compared. It has also been shown that using a ramp-protocol with 
small increments (≤15watts/min) mitigates the lag of VO2 response in recreationally trained men 
and women and allows for the mean response time (MRT) of VO2 to meet the requirements of the 
test (Iannetta et al., 2019). Additionally, using a small increment protocol mitigates the differences 
between expected and actual VO2 at a given work rate, making it more comparable to steady state 
predictions. For these reasons, using PPO to calculate percentages of VO2 peak on a ramp test is a 
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reasonable approach, allowing for comparison to prior studies that have used submaximal, steady 
state bouts.   
 To report valid RER averaging, it is important to consider the rationale behind averaging 
the data itself for further statistical analysis. For aim 1a and aim 2a, RER will be compared at 3 
time points that parallel 40, 60, and 70% of projected VO2 max, based upon previous literature 
(Tosti et al., 2011). By matching these timepoints, the discussion can focus on comparing to, and 
expanding upon, preliminary findings during acute bouts of steady state exercise. However, the 
averaging window used by Tosti. et al. (Tosti et al., 2011) was the last 5-minutes of a 9-minute 
bout of cycling. Due to the nature of the ramp protocol proposed, the RER averaging window must 
be far smaller to best align with the timepoints of 40, 60 and 70% of PPO. A 30-second window 
would allow for one RER measure exactly equal to the timepoint of interest, along with 2 more 
timepoints either side of the middle point (using 5-second averaging outputs) for a total of 5 RER 
measurements. 
 For aim 1c and aim 2c, a continuous method will be used to analyze RER. Although this 
approach is less comparable to prior literature described above, examination of the data in a 
continuous fashion may provide more insight as the metabolic demands shift predominantly from 
aerobic pathways to anaerobic pathways during the ramp progression of the CPET. By analyzing 
time points across the duration of the test, the continuous approach can help elucidate on which 
intensities may present dissimilitude between the metabolic response of BCa survivors and HCs. 
Due to the different maximal PPOs recorded amongst participants, each test was normalized as a 
percentage of PPO, similar to the approach in aim 1a and aim 2a. Then, the closest corresponding 
RER value at each 5% increment (starting at 25%) was recorded for statistical analysis. A starting 
point of 25%, progressing at 5% increments, was selected based on the average PPO output across 
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participants. All percentages that occurred during the warm-up were excluded since this was a 
fixed wattage for 3 minutes as opposed to the 15w/min ramp implemented following the warm-up 
stage. Additionally, an increment of less than 5% would have been too difficult to obtain 
appropriate values for each corresponding RER measure due to the relatively low PPO outputs that 
were recorded. Theoretically, the physiological response of VCO2 and VO2 (the ratio of which is 
RER) to increasing workload is not linear (Brooks, Fahey, & Baldwin, 2005) (Fig. 1; “Normal 
Response”). Particularly, as an individual relies predominantly on anaerobic pathways for energy 
production the relationship of VCO2 and VO2 increases more rapidly than during reliance on 
aerobic systems. Because of this phenomenon, it must be assumed that the relationship of RER vs. 
workload is non-linear in nature. For these reasons a non-linear regression approach is the correct 
decision to further understand how BCa survivors and HC respond to a non-steady state CPET.   
 
Figure 1. Theoretical depiction of respiratory exchange ratio vs. % of peak power output (PPO) 
during normal and abnormal metabolic responses for incremental exercise. 
y = 0.591x2 - 0.2271x + 0.8455
R² = 0.9967































 The goal of aim 3 was to further investigate the relationship between aerobic and anaerobic 
metabolism in BCa survivors and HC. Because this was exploratory, a visual analysis of graphical 
data was conducted followed by calculation of effect sizes. Theoretically, when comparing RER 
(the ratio of VCO2 and VO2) against workload, VCO2 will increase more rapidly than VO2 
following the first ventilatory threshold (1VT) (Mezzani, 2017). This phenomenon occurs due in 
largely to a build-up in lactic acid buffering that generates excess CO2. More specifically, as lactic 
acid accumulates in the muscle through anaerobic processes, bicarbonate reacts with the protons 
(H+) attached to lactic acid to form carbonic acid. The carbonic acid can then dissociate into CO2 
and water, creating the excess seen around 1VT. As such, the 1VT, which should be approximately 
at an RER of 1.00, indicates a predominantly anaerobic system for the remainder of the CPET. In 
order to determine the secondary ventilatory threshold (2VT), the intersection of ventilatory 
equivalent of oxygen (VE/VO2) and the ventilatory equivalent of carbon dioxide (VE/VCO2) can 
be utilized. The cross-over point can be an indicator of hyperventilation, further impacting the 
RER measure in question by driving VCO2 higher (Mezzani, 2017). For analysis purposes, the 
2VT was analyzed as this is most commonly referred to as the anaerobic threshold (AT).  
 Because the purpose of this aim is to further investigate the differences of anaerobiosis in 
BCa survivors and HC, selecting the 2VT ensures that participants were contributing heavily with 
anaerobic pathways during the final portion of the CPET. Due to the current literature presenting 
diminished lactate levels throughout submaximal intensities (Evans et al., 2009; Tosti et al., 2011), 
it was hypothesized that limited lactate production in BCa survivors may indicate metabolic 
dysfunction, further impacting the anaerobic responses during a maximal effort test and causing 
irregular measures beyond the LT. Furthermore, because lactate production is lower in BCa, the 
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increase in RER rate following the 2VT may be indistinct, or even non-existent, in BCa compared 









CHAPTER III: METHODOLOGY 
Participants 
 BCa patients recruited for this study met the following inclusion criteria: early stage (0-
III), non-metastatic BCa survivors that completed primary treatment (chemotherapy, radiation, 
surgery) within the last year; continuation of hormone therapy or non-adjuvant treatments were 
permittable. Exclusion criteria included: any participant exhibiting non-cancer related diseases or 
ailments that may inhibit performance on exercises. A sedentary-healthy control group was age 
matched to the BCa survivor cohort. Menopausal status will not be controlled for either group 
during the study. Both groups completed the same aerobic/resistance exercise training program. 
Study approval was obtained from the protocol review committee at UNC’s Lineberger 
Comprehensive Cancer Center and the UNC School of Medicine Institutional Review Board. All 
participants provided written informed along with oncologist clearance (BCa only) for 
participation prior to completion of any testing.  
Study Design 
 This study served as a retrospective analysis compiling data from a larger experiment. The 
main objective of the overall experiment was to evaluate the efficacy of a community-based 
exercise program on aerobic capacity. The design was a non-randomized, two-arm, interventional 
study. Within this particular study, the participants took part in two laboratory visits prior to 
implementation of the 16-week combined training program. The laboratory visits were conducted 
in the Exercise Oncology Research Laboratory (EORL) at University of North Carolina at Chapel 
Hill (UNC-CH). Pre-intervention visits were conducted within 2 weeks prior to initiation of the 
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exercise training program. Visit 1 consisted of an initial screening, body composition assessments, 
and a submaximal familiarization to the cycle ergometer in preparation for a maximal CPET. Visit 
2 consisted of a maximal CPET. The training program was conducted at the GRH facility on the 
UNC-CH campus. The exercise sessions were designed, instructed, and monitored by experienced 
exercise trainers. All participants then completed the exercise intervention (described below). 
Upon completion of the 16-week intervention, visit 2 was completed again in its entirety to collect 
post-intervention assessments.  
Pre-/Post-intervention Assessments 
Visit 1 
 Prior to visit 1, participants were provided a list of pre-assessment guidelines that must be 
followed in order to participate. The guidelines were listed as follows: Arrive fasted, no caffeine 
prior to testing, and encouraged to maintain hydration. After meeting pre-assessment guidelines, 
participants then provided demographic information to the researcher. Participants were then 
screened via a physical activity readiness questionnaire (PAR-Q) and 12-lead electrocardiogram 
(ECG) per manufacturer’s instructions. The 12-lead ECG results, medical history questionnaire, 
and PAR-Q were reviewed and approved by the cardiology study physician prior to visit 2. Body 
composition was assessed using whole-body dual-energy x-ray absorptiometry (DEXA) 
(Discovery W, model QDR 4500AHologic, Waltham, MA, USA) to determine fat mass (FM) and 
fat free mass (FFM). Scans were performed and analyzed by two certified densiometrists and the 
machine was calibrated daily. To prepare for visit 2, participants were familiarized with the 
maximal CPET on the cycle ergometer. Familiarization consisted of being fitted with a mask and 
HR monitor to then follow a ramp protocol. The familiarization session was terminated once the 
participant reached ~75% heart rate reserve (HRR). This process allowed the individual to adapt 
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to the ramp-protocol progression of the test and become familiar with the Borg RPE scale (Borg, 
1982). 
Visit 2 
 As in visit 1, visit 2 consisted of similar pre-assessment guidelines with the caveat of 
admittance of food prior to testing. This ensured participants felt at their best prior to fully exerting 
themselves on an exercise test. Prior to the maximal CPET, participants were fitted with a HR 
monitor and a mask. The cycle ergometer’s seat height and handlebar angle were set appropriately 
for each participant. Once seated on the cycle ergometer, participants rested for 3 minutes to collect 
metabolic data using a Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, Salt Lake 
City, UT USA.).  
 The same ramp-protocol, as used in the familiarization, involved participants cycling for 2 
minutes unloaded (0 watts) followed by a 3-minute loaded (20 watt) warm-up. The test itself then 
proceeds at a 15 watt/min progressive ramp-protocol. The ramp protocol was selected for the 
purpose of obtaining another outcome related to the overall study. However, it has been shown 
that using a ramp-protocol with small increments (≤15watts/min) mitigates the lag of VO2 response 
and allows for the mean response time (MRT) of VO2 to meet the requirements of the test (Iannetta 
et al., 2019). HR data and RPE were collected 15 seconds prior to the end of each stage. Pre-
determined guidelines for test termination were: voluntary termination by participant, VO2 plateau 
or decrease with increasing workload, or adverse events to exercise bout. VO2 peak was then 
calculated using an average of the 3 highest values recorded in the final minute prior to test 
termination. 
 BL measurements were taken 3-minutes post-termination of the test (3MBL). Immediately 
following exhaustion, participants were moved to a seat position to recover with their legs 
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elevated. After ~3 minutes, peak lactate concentration was determined using a finger stick and 
capillary sampling via a Lactate Plus Analyzer (Nova Biomedical, Waltham, MA, USA).  
Metabolic Data Analysis 
 For aim 1a and aim 2a, all metabolic data was analyzed using a 5-second averaging. Due 
to the lack of steady state within the CPET protocol, important steps were taken to average the 
RER data to best produce an estimation of 40%, 60%, and 70% of VO2 peak. To derive 40, 60, 
and 70% of VO2 peak, PPO was an appropriate option due to its linear consistency throughout 
submaximal ranges (Zoladz et al., 1995). However, the location of the wattage corresponding to 
40%, 60%, and 70% of PPO may not be directly correlated to the 40%, 60%, and 70% of VO2 
peak, due to a starting point of 0 watts and a non-zero resting VO2 measurement. A 30-second 
window was used to average both the VO2 and RER data surrounding the time point associated 
with the % of PPO calculated. To ensure no skew, the window should encompass the PPO, placing 
it as the median value in the data set.  
 For aim 1c and aim 2c, metabolic data was collected by averaging the RERs closest to each 
percentage of PPO for each CPET conducted. Similar to aim 1a and aim 2a, the correlation of RER 
versus wattage suggests that there is a linear relationship at submaximal intensities (Zoladz et al., 
1995) that is not present at higher efforts. In order to analyze a non-linear relationship, a non-linear 
multiple regression was conducted. As it was initially unknown as to whether this relationship was 
exponential or polynomial in nature, a curvilinear estimation test was performed to determine the 
appropriate regression modeling.  
 The exploratory aim used the ventilatory equivalent (VEQ) method (Gaskill et al., 2001) 
to determine the VT of each CPET. By comparing VE/VCO2 to VE/VO2, VT was identified at the 
point in which the values intersect on a graph (Fig. 2). Using a moving average trendline with a 
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period of 2 time points allowed for the most accurate determination of this data point in a noisy 
dataset. Upon determination of 2VT, the graphical representation of VCO2 and VO2 was analyzed. 
The linear slope from test initiation to 2VT and the linear slope from 2VT to test termination was 
calculated along with the coefficient of determination for each line (Fig. 3). The accuracy of each 
slope calculation was determined by an outlier test using the interquartile range (IQR) on the 
coefficients of determination. Those below Q1 were removed. Additionally, if a test only had 2 
data points for a given slope, the data was excluded due to a coefficient of determination equal to 
1. Effect sizes were then calculated for the change in slope variable. Comparisons between BCa 
survivors and HC before and after a combined exercise training were made. For more details on 
metabolic data processing and rationale, see Chapter 2 (Section 6).  
 
Figure 2. Example of ventilatory equivalents (VEQ) method for ventilatory threshold (VT) 
















2 per. Mov. Avg. (VE/VCO2) 2 per. Mov. Avg. (VE/VO2)
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Figure 3. Example of carbon dioxide output (VCO2) vs. oxygen uptake (VO2) slope analysis. 
Black represents the slope from initiation to ventilatory threshold (VT) and grey represents the 
slope from VT to test termination.  
Combined Training Intervention 
 Initiation of the training intervention occurred within 2 weeks following visit 2 completion. 
The intervention spanned 16 weeks and included 3 days of combined activity per week. Each 
session encompassed up to 30 minutes of AET and up to 30 minutes of RT, introduced in a 
progressive manner. To allow for completion of the intervention, any modifications made to 
certain movements due an inability to perform the exercise were allowed and noted.  
Aerobic Training  
  Aerobic exercise was preferentially selected by participants each day and included 
treadmill walking/jogging, stationary bicycle, rower, elliptical, and/or seated stepper. The first 2 
weeks of the program prescribed 10-15 minutes of aerobic activity at an RPE of 8-11. The first 7 
weeks of the program followed the same intensity, but increased the durational window from 10-
15 minutes to 10-30 minutes following completion of week 2. After week 7, intensity increased to 
y = 0.9298x - 0.0675
R² = 0.9795




















an RPE range of 12-14 (Table 1, see below). Additionally, participants were expected to complete 
an aerobic bout of 30 minutes each training session for the remainder of the intervention.  
Resistance Training  
 RT was prescribed for participants each session. Each workout consisted of 6 exercises, 
programmed to target major muscle groups. Additionally, balance movements were incorporated 
throughout the 6 exercises. The first 2 weeks consisted of 1 set of 10-15 repetitions of each 
exercise. Weeks 3-5 progressed to 2 sets of 10-15 repetitions of each exercise. The intensity 
throughout the first weeks was within an RPE range of 7-13. As participants adapted to RT, the 
intensity increased after week 5 to an RPE range of 14-15, still continuing 2 sets of at least 10 
repetitions for each exercise (Table 1, see below).    
Table 1. Community-based exercise training progression. 
Aerobic Exercise 
Intervention 
Weeks 1-2 Weeks 3-7 Weeks 8-16 
Duration (min) 10-15 10-30 30 
Intensity Low Moderate 
RPE 8-11 12-14 
Resistance Exercise 
Intervention 
Weeks 1-2 Weeks 3-5 Weeks 6-16 
Duration (min) 30 
RPE 7-13 14-15 
Sets x Reps 1 x 15 2 x 10-15 2 x10 
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Statistical Analyses  
 All statistical analyses were conducted using Statistical Package for Social Sciences 
(SPSS) version 26.0 (IBM, Armonk, NY). Alpha levels were set at <0.05 a priori for all subsequent 
analyses. Data will be reported using means and 95% confidence intervals. Additionally, all 
Cohen’s d were calculated and interpreted as follows: Trivial, d < 0.2; small, d > 0.2; medium, d 
> 0.5; large, d > 0.8. For participant demographics and CPET termination reasoning, chi-square 
analyses were performed. 
Objective 1 – Confirmatory Aim 
• Hypothesis 1a: Compared to HC, respiratory exchange ratio (RER) at 40, 60, and 70% of 
peak power output (PPO) will be lower in BCa survivors prior to training. A 2 x 3 mixed 
model (group x intensity) ANOVA was conducted using Tukey-honestly significant 
difference (HSD) post-hoc analysis to determine main effects.  
• Hypothesis 1b: Compared to HC, Post CPET lactate measures will be lower in BCa 
survivors prior to training. An independent samples t-test was used to determine the 
differences in lactate production between BCa survivors and HC.  
• Hypothesis 1c. Compared to HC, RER will remain lower in BCa at increasing percentages 
of PPO throughout the duration of the CPET. A quadratic hierarchical multiple regression 
was run to optimize the predictive model of intensity/group and RER.  
Objective 2 – Primary Aim 
• Hypothesis 2a: Compared to HC, change scores (POST-PRE) in RER at 40, 60 and 70% 
of PPO will be larger in BCa survivors following completion of a combined training 
program. A 2 x 3 mixed model (group x intensity) ANOVA was be conducted using 
Tukey-honestly significant difference (HSD) post-hoc analysis to determine main effects.  
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• Hypothesis 2b: Post CPET lactate measures will be the same between BCa survivors and 
HC following completion of a combined training program. A 2 x 2 (group x training) 
ANOVA was used to determine the differences in lactate production between BCa 
survivors and HC. 
•  Hypothesis 2c. Compared to baseline, RER will be lower at increasing percentages of 
PPO for BCa survivors and HC controls following completion of a combined training 
program.  A quadratic hierarchical multiple regression was run to optimize the predictive 










CHAPTER IV: RESULTS 
Demographics 
Pre-Training  
 A total of 35 BCa survivors and 21 HC were recruited into the study. Of these, 34 BCa 
survivors and 21 HC were used in analyses for Aim 1. The sample was predominantly white 
(~85%), there were no differences in age [mean difference (MD)=0yrs; 95% CI (-6, 6)], mass 
[MD=-0.7kg; 95% CI (-7.8, 6.3)], and BMI [MD=-1.9kg/m2; 95% CI (-4.6, 0.8] between groups 
(Table 2). However, BCa survivors were taller than HC at baseline [MD=5.2cm; 95% CI (1.4, 
9.1)]. Notably, the majority of patients underwent radiation therapy (~72%).  
Table 2. Baseline characteristics of female breast cancer (BCa) survivors and healthy 
controls (HC). 
 
BCa (n=34) HC (n=21) P-value 
Age (years) 55 (11) 54 (8) 0.950 
Height (cm) 167.1 (7.2) 161.9 (6.4) 0.009 
Mass (kg) 76.2 (12.0) 76.9 (13.9) 0.833 
Body mass index (kg/m2) 27.4 (4.9) 29.3 (4.9) 0.164 
Race*   0.710 
   Caucasian, n (%) 28 (85) 18 (86) - 
   African American, n (%) 4 (12) 3 (14) - 
   Asian, n (%) 1 (3) 0 (0) - 
Treatment type*    
   Chemotherapy, n (%) 5 (15) - - 
   Radiation, n (%) 12 (36) - - 
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   Combination, n (%) 12 (36) - - 
   Surgery, n (%) 4 (12) - - 
Data reported as mean (standard deviation) 
*Missing for race [BCa: (n=1)] and treatment type (n=1) 
 
 Comprehensive CPET data was collected and analyzed on participants that successfully 
completed the protocol. At baseline, maximal RPE was slightly higher in HC than BCa survivors 
prior to training [MD=1; 95% CI (0, 2), Table 3]. VO2 peak [MD=-0.4ml/kg/min; 95% CI (-2.9, 
2.2)], maximal RER [MD=0.01; 95% CI (-0.06, 0.07)], PPO [MD=-8.0w; 95% CI (-20.8, 4.8)], 
and MHR [MD=2bpm; 95% CI (-8, 13)] all showed no differences between groups at baseline.  
Table 3. Baseline preliminary cardiopulmonary exercise test (CPET) 
results. 
 
BCa (n=34) HC (n=21) P-value 
VO2 peak (ml/kg/min) 20.8 (5.0) 21.2 (3.9) 0.774 
Max RER (n/a) 1.21 (0.13) 1.20 (0.10) 0.846 
PPO (watts) 118.9 (24.6) 126.9 (19.8) 0.214 
Max HR (bpm) 160 (20) 158 (16) 0.643 
Max RPE (n/a) 17 (2) 18 (1) 0.006 
Reason for termination*     0.959 
   Leg fatigue, n (%) 16 (52) 10 (48) - 
   CP fatigue, n (%) 7 (22) 5 (24) - 
   Combination, n (%) 8 (26) 6 (28) - 
Data reported as mean (standard deviation) 
CP = cardiopulmonary 
*Missing data for reason for termination [BCa (n=3)] 
Post-Training 
 Of the 34 BCa survivors and 21 HC that began the 16-week combined training intervention, 
31 and 15 participants respectively completed the post-training CPET and were included within 
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the Aim 2 analyses. Reasons for dropping out were: too busy (n=4), moved away (n=1), failed to 
respond to follow ups (n=3), and chose to withdraw (n=1). BCa survivor height remained taller 
than HC following training [MD=4.9cm; 95% CI (0.4, 9.5); Table 4]. There were no differences 
in age [mean difference (MD)=0yrs; 95% CI (-7, 7)], mass [MD=1.7kg; 95% CI (-6.6, 10.0)], and 
BMI [MD=-0.9kg/m2; 95% CI (-4.1, 2.3)] between groups (Table 4).   
 
 Following training, VO2 peak increased [MD=1.2ml/kg/min; 95% CI (0.1, 2.3); Table 5] 
with no interaction or group differences. Additionally, PPO demonstrated a group x training 
interaction, where BCa survivors produced higher outputs than HC after training [∆BCa: 16w; 





(n=15) Post-HC  






Age (years) 55 (12) - 55 (8) - - - 0.965 
Height (cm) 167.1 (7.1) 167.1 (7.1) 162.1 (7.4) 162.1 (7.4) 0.232 0.579 0.035 
Mass (kg) 76.7 (12.3) 76.8 (12.4) 75.5 (13.8) 74.7 (15.4) 0.233 0.402 0.682 
Body mass index (kg/m2) 27.6 (5.0) 27.7 (5.0) 28.9 (4.8) 28.4 (5.2) 0.172 0.323 0.504 
Race*      0.138  
   Caucasian, n (%) 26 (87) - 15 (100) - - - - 
   African American, n (%) 4 (13) - 0 (0) - - - - 
   Asian, n (%) 0 (0) - 0 (0) - - - - 
Treatment type*        
   Chemotherapy, n (%)  5 (17) - - - - - - 
   Radiation, n (%) 12 (40) - - - - - - 
   Combination, n (%) 10 (33) - - - - - - 
   Surgery, n (%) 3 (10) - - - - - - 
Data reported as mean (standard deviation) 
G= group; T= training; Pre= pre-training; Post= post-training 
*Missing data for race [Pre-BCa: (n=1)] and treatment type (n=1) 
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95% CI (11, 21); p<0.001; ∆HC: 7w; 95% CI (1, 12); p=0.020]. Maximal RPE trended lower 
following training, however the effect was trivial [MD=-1; 95% CI (0, 1); d=0.17; Table 5], with 
no group differences. Synonymous with baseline, maximal RER and MHR showed no differences 
between groups or across training status. Additionally, reason for termination frequencies 
remained similar across groups. 
















VO2 peak (ml/kg/min) 20.9 (5.3) 22.2 (5.4) 22.4 (2.8) 23.5 (4.5) 0.942 0.029 0.337 
Max RER (n/a) 1.21 (0.13) 1.23 (0.12) 1.22 (0.07) 1.23 (0.05) 0.204 0.835 0.768 
PPO (watts) 119.8 (25.6) 136.0 (30.1) 130.0 (20.1) 136.7 (21.7) 0.020 <0.001 0.496 
Max HR (bpm) 160 (20) 160 (17) 159 (12) 159 (14) 0.839 0.995 0.872 
Max RPE (n/a) 17 (2) 17 (2) 18 (1) 17 (2) 0.114 0.083 0.122 
Reason for termination*         0.353 
   Leg fatigue, n (%) 15 (58) 13 (50) 5 (46) 3 (27) - - - 
   CP fatigue, n (%) 5 (19) 8 (31) 1 (9) 6 (55) - - - 
   Combination, n (%) 6 (23) 5 (19) 5 (46) 2 (18) - - - 
Data reported as mean (standard deviation) 
G= group; T= training; Pre= pre-training; Post= post-training; CP = cardiopulmonary 
*Missing data for reason for termination [Post-BCa (n=5); Post-HC (n=4)]; % may not add up to 100% due to rounding 
 
RER Analysis at 40%, 60%, and 70% of PPO  
Aim 1a 
 Aim 1a analyzed the differences between RER measures at 40%, 60%, and 70% of PPO in 
both BCa survivors and HC. Prior to training, overall RER values increased from 40% to 60% to 
70% of PPO, with all simple main effects being different from each other (all p<0.001; Fig. 4A). 




Figure 4. A) Pre- vs. B) post-training intervention comparison of respiratory exchange ratio and 
% of peak power output (PPO) during a cardiopulmonary exercise test in breast cancer survivors 
(BCa: Pre-, n=34; Post-, n=31) and healthy controls (HC: Pre-, n=21; Post-, n=15). 
*p<0.05 vs. 40% of PPO  
^p<0.05 vs. 60% of PPO 
Aim 2a 
 Aim 2a expanded on aim 1a by incorporating the impacts of a training intervention on RER 
measures at 40%, 60%, and 70% of PPO. Following combined exercise training, there were no 
differences between change scores (Post-training RER – Pre-training RER) at 40%, 60% or 70% 
of PPO [40% vs. 60%: MD=0.00, 95% CI (-0.03, 0.02); 40% vs. 70%: MD=0.00, 95% CI (-0.02, 
0.02); 60% vs. 70%: MD=0.00, 95% CI (-0.02, 0.02); p=0.913; Fig. 4B] or between groups 

























































Blood Lactate Analysis 
Aim 1b 
 Aim 1b compared pre-training blood lactate responses following maximal exertion on a 
CPET. There was a trend towards higher 3MBL concentrations in HC compared to BCa survivors 
[MD=0.8mmol/L; 95% CI (-0.3, 1.9); p=0.072; d= 0.41; Fig. 5].  
  
Figure 5. Pre-training intervention comparison of blood lactate concentrations following a 
cardiopulmonary exercise test in breast cancer survivors (BCa, n=33) and health controls (HC, 
n=21). BCa is reported as a subsample (n=33 out of 34 total). 
Aim 2b 
 Aim 2b investigated the impacts of a combined training intervention on the results provided 
in aim 1b. Post-training measures demonstrated a trend towards higher 3MBL compared to pre-
training testing [MD=0.5mmol/L; 95% CI (0.0, 1.0); p=0.075; d= 0.28; Fig. 6]. However, there 





















Figure 6. Post-training intervention comparison of blood lactate concentrations following a 
cardiopulmonary exercise test in breast cancer survivors (BCa, n=28) and health controls (HC, 
n=15). BCa is reported as a subsample (n=28 out of 31 total). 
Continuous RER Analysis 
Aim 1c 
 Aim 1c analyzed the substrate utilization continuously throughout the duration of a CPET, 
as opposed to pre-selected intensities. Due to the non-linear nature of RER response across 
increasing workload, a polynomial regression model approach was taken using a hierarchical 
approach (Fig. 7). Prior to training, intensity2 was a predictor of RER (adj. R2=0.995; p<0.001; 
Model 1, Table 6). However, the addition of group followed by intensity2 x group were not 

























Figure 7. Pre-training comparison of respiratory exchange ratio and % of peak power out (PPO) 
during a cardiopulmonary exercise test in breast cancer survivors (BCa, n=34) and health controls 
(HC, n=21).  
Table 6. Pre-training intervention respiratory exchange ratio 
modeling using hierarchical multiple regression. 
 Intensity Intensity2 Group Int x  Group 
Int2 x  
Group 
Model 1      
   ß  -0.285 1.278 - - - 
   SE 0.000 0.000 - - - 
   P  0.001 <0.001 - - - 
Model 2      
   ß -0.285 1.278 -0.016 - - 
   SE 0.000 0.000 0.003 - - 
   P 0.001 <0.001 0.188 - - 
Model 3      
   ß -0.395 1.38 -0.159 0.336 -0.212 
   SE 0.001 0.000 0.022 0.001 0.001 
   P 0.001 <0.001 0.093 0.145 0.174 































 Aim 2c further analyzed substrate utilization through the addition of training effects into 
the aim 1c modeling system. The non-linear RER response across increasing workload persisted 
post-training (Fig. 8B).  
 
Figure 8. A) Pre- vs. B) post-training intervention comparison of respiratory exchange ratio and 
% of peak power output (PPO) during a cardiopulmonary exercise test in breast cancer survivors 
(BCa, n=31) and health controls (HC, n=15).  
 Similar to pre-training, intensity2 was a predictor of RER (adj. R2=0.987; Model 1, Table 
7). When adding the training predictor, the overall model fit improved (Model 2, adj. ∆R2=0.007, 
p<0.001). However, inclusion of the interaction term of intensity2 x training (Model 3, adj. 
∆R2<0.000, p=0.135) did not further improve the model. The addition of group to model 4 had no 






























































term into model 5 could not be interpreted due to no main effect of group. Lastly, the inclusion of 
the intensity2 x group x training interaction term had no impact on model fit (Model 6). 
Table 7. Pre and Post-training intervention respiratory exchange ratio modeling using hierarchical 
multiple regression. 
 Intensity Intensity2 Training Int x T Int2 x T Group Int x G Int2 x G Int2 x G x T 
Model 1          
   ß  -0.164 1.155 - - - - - - - 
   SE 0.000 0.000 - - - - - - - 
   P  0.076 <0.001 - - - - - - - 
Model 2          
   ß -0.164 1.155 0.086 - - - - - - 
   SE 0.000 0.000 0.002 - - - - - - 
   P 0.009 <0.001 <0.001 - - - - - - 
Model 3          
   ß -0.282 1.267 -0.065 0.361 -0.231 - - - - 
   SE 0.000 0.000 0.018 0.001 0.000 - - - - 
   P 0.001 <0.001 0.391 0.054 0.068 - - - - 
Model 4          
   ß -0.282 1.267 -0.065 0.361 -0.231 -0.172 - - - 
   SE 0.000 0.000 0.019 0.001 0.000 0.002 - - - 
   P 0.002 <0.001 0.395 0.070 0.056 0.864 - - - 
Model 5          
   ß -0.424 1.408 -0.065 0.361 -0.231 -0.171 0.433 -0.293 - 
   SE 0.001 0.000 0.018 0.001 0.000 0.018 0.001 0.000 - 
   P <0.001 <0.001 0.379 0.048 0.062 0.023 0.019 0.019 - 
Model 6          
   ß -0.424 1.412 -0.065 0.361 -0.240 -0.171 0.433 -0.302 0.014 
   SE 0.001 0.000 0.018 0.001 0.000 0.018 0.001 0.000 0.000 
   P <0.001 <0.001 0.379 0.048 0.062 0.023 0.019 0.019 0.423 




 Aim 3 explored potential differences for the relationship of VCO2 and VO2 before and after 
reaching VT. Averages for all pre-VT slopes were just below 1, indicating an almost a 1-to-1 ratio 
for VCO2 and VO2 responses up until VT (Table 8). As participants relied more on anaerobic 
pathways, all post-VT slope averages rose above a value of 1, indicating greater increases in VCO2 
compared to VO2. Additionally, the average coefficients of determination for pre-VT data 
appeared slightly higher compared to post-VT R2 values across all groups and training status. 
Table 8. Pre- and Post-ventilatory threshold (VT) slope analysis of female breast cancer (BCa) survivors 









Pre-VT	Slope (VCO2/VO2) 0.96 (0.04) 0.98 (0.05) 0.96 (0.04) 0.97 (0.02) 
Pre-VT R2 0.98 (0.01) 0.98 (0.01) 0.98 (0.01) 0.98 (0.01) 
Post-VT Slope (VCO2/VO2) 1.44 (0.30) 1.34 (0.30) 1.51 (0.22) 1.38 (0.17) 
Post-VT	R2 0.89 (0.08) 0.88 (0.10) 0.91 (0.05) 0.89 (0.08) 
△	Slope (Post-Pre)	 0.48 (0.31) 0.36 (0.30) 0.56 (0.24) 0.41 (0.19) 
Data reported as mean (standard deviation) 
Pre= pre-training; Post= post-training; RER= respiratory exchange ratio; PPO= peak power output; R2 = 
coefficient of determination for slope values 
  
 Change in slope was addressed as a variable that could be informative about metabolic 
pathway reliance throughout a ramp-protocol CPET. To compare the groups and change across 
training, Cohen’s d effect sizes were calculated for change in slope values (Table 8). There were 
2 comparisons (Pre-HC vs. Pre-BCa: d=0.29); Post-HC vs. Post-BCa: d=0.20) that demonstrated 
small effect sizes between groups. The pre-post training effects for BCa (d=0.39) and HC (d=0.69) 







CHAPTER V: DISCUSSION  
Overview 
 Throughout and following breast cancer therapy, more women are in need of structure for 
their survivorship, with the aim of mitigating the long-term impacts of treatment. Combined 
exercise training is well-established in its positive impacts on a multitude of cancer-related side 
effects (Battaglini et al., 2014; Galvão & Newton, 2005; McNeely et al., 2006; Mock et al., 1997; 
C. M. Schneider et al., 2007), with community-based exercise training serving as a feasible 
alternative to home-based or 1-on-1 programs (Amatuli, 2020; Foley & Hasson, 2016; Nock et al., 
2015; Rajotte et al., 2012). Metabolic dysfunction is a side effect arguably interconnected with 
many of the other, more heavily studied effects such as fatigue, physical function, and QoL. 
However, there is a lack of understanding regarding the impacts of exercise on metabolic 
dysfunction within these studies. Therefore, the purpose of this study was to investigate the effects 
of a community-based 16-week combined exercise intervention on metabolic function in BCa 
survivors and HC during acute, incremental exercise. Prior to training, BCa survivors showed few 
differences to HC, with the exception of a trend towards differences in 3MBL (p=0.072; d= 0.41). 
Training appeared to have little impact on RER at submaximal intensities, however, 3MBL trended 
higher in both groups (p=0.075; d= 0.28). This study suggests that implementation of a combined 
training intervention has the potential to improve anaerobic parameters of metabolic dysfunction. 
However, study results suggesting metabolic improvements in anaerobic measures, and lack 
thereof in more aerobic measures, contradict previous steady-state findings conducted using acute 
exercise bouts.  
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Limitations and Strengths 
 The limitations and strengths of this study are provided to give context for the results. Due 
to retrospective study design, this study used non-steady RER values obtained during a CPET. As 
a result of the ramp protocol test progression, there is a disconnect between RER and the 
respiratory quotient that is measured at the cellular level (Gupta et al., 2017). Hyperventilation will 
further drive VCO2 at the mouth during intensities beyond VT, causing a difference between the 
RER measure and the true RQ. To potentially counteract this limitation, a ≤15w/min ramp-protocol 
was selected based on previous literature that suggests slower progression protocols better account 
for the lag in VO2 measurements (Iannetta et al., 2019). Additionally, the use of submaximal 
intensities allows for the comparison of ramp-protocol % PPO measures from this study and 
steady-state % VO2 measures from previous literature due to the linear relationship between VO2 
and workload at sub-VT intensities (Zoladz et al., 1995).  Another metabolic data limitation is the 
collection of peak vs. max cardiopulmonary exercise tests. Because participants were unable to 
meet 3 of the 5 qualifying criteria for a max test, all BL measures cannot be considered as maximal 
values for a participant. Additionally, percentages are based off of VO2 peak measures and may 
not be as comparable to previous literature that used VO2 max predictive models. Lastly, a small 
sample size possibly attributed to the abundance of trending results (p<0.10) as opposed to 
significant findings.  
 This study had multiple strengths. First, this was the only known study to address the 
impacts of a training intervention on metabolic dysfunction in BCa survivors. Additionally, the 
implemented training intervention is in compliance with the exercise prescription guidelines 
(Campbell et al., 2019; Hayes et al., 2019), providing an appropriate design for eliciting beneficial 
physiological changes in BCa survivors. Finally, this study addresses incremental exercise at 
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various intensities as opposed to focusing on steady-state metabolism, an approach that has yet to 
be analyzed in the field.  
Similarities of RER Analysis at 40%, 60, and 70% of PPO 
Aim 1a 
 Hypothesis 1a aimed to address substrate utilization at various submaximal intensities 
during a CPET performed prior to exercise training. RER was analyzed at 40%, 60%, and 70% of 
PPO to ensure the most direct comparisons to previous literature. RER differed across intensities 
(all p<0.001), albeit there were no differences between groups. The lack of group differences 
contrasts previous research. Tosti et al. (2011) found that compared to healthy controls, BCa 
survivors tend to oxidize fats at higher rates than CHOs during a steady-state exercise (Tosti et al., 
2011). The use of a steady-state vs. the non-steady state protocol in the current study may 
contribute to these conflicting results. Specifically, during a non-steady state bout, the metabolic 
response is continually adapting to accommodate the workload added. Because of this constant 
change, metabolic measurements may be different during incremental cycling as opposed to a 
continual cycling bout. Additionally, the lack of group differences seen at pre-training could be 
due to the sedentary nature of the control group. A major assumption made during recruitment was 
HCs would not present with metabolic dysfunction of their own. However, sedentary behavior and 
lack of moderate to vigorous physical activity (MVPA) can contribute to MetSyn in otherwise 
healthy populations (Ford, Kohl, Mokdad, & Ajani, 2005). Due to the lack of objective PA 
monitoring and unknown sedentary status, it is possible the HC group may have been presenting 
metabolic dysfunction from non-cancer related reasons at baseline, further diminishing potential 
group differences.  
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Aim 2a 
 Following training, change scores indicated that both group and intensity differences were 
non-significant. This result suggests that there are no impacts of training specifically on low, 
moderate and/or high intensity metabolic responses in either group, when examined using fixed 
workloads. Although, it is worth noting that all mean change scores were positive, suggesting 
training may increase overall RER throughout a CPET. Based on the statistical results and small 
effect sizes of this aim, it may be that the training stimulus was not enough to promote metabolic 
changes such as improved glycolytic reliance and/or muscular fitness adaptations that would alter 
RER measures. Furthermore, there could have been less metabolic dysfunction than anticipated at 
baseline in BCa survivors, diminishing the potential for positive training impacts. However, there 
were no measures taken at baseline to directly compare the metabolic function of each group. 
Suggestive Differences for Blood Lactate Analysis 
Aim 1b 
 Hypothesis 1b compared 3MBL values following maximal exertion on a CPET before 
implementation of the training intervention. At baseline, 3MBL trended slightly higher in HC 
(d=0.41; p=0.072). Although non-significant, this finding is consistent with Tosti et al. and Evans 
et al., who both demonstrated higher BL in controls at 70% of VO2 peak (Evans et al., 2009; Tosti 
et al., 2011). A lack of significance with this result is most likely due to the small sample size 
within the study. Although BL was also reportedly higher at 40% and 60% steady-state bouts 
(Tosti et al., 2011), the comparison of those results to a maximal effort 3MBL in this study is 
unreasonable. Lowered lactate production seen in BCa survivors could be a result of the Warburg 
Effect. As cancer develops, the tumor itself relies heavily on lactate as a fuel source from continued 
growth. To combat cell replication, the body begins relying on alternative fuel sources and 
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producing less lactate to starve the tumor (Gentric et al., 2017). However, following treatment this 
mechanism may still exists within the BCa survivor, although the tumor has been addressed 
through therapy. This rationale implies that the Warburg Effect may have a more prolonged 
systemic impact, lowering CHO and lactate usage in healthy cells and promoting reliance on 
alternative fuels such as lipids and proteins.  
Aim 2b 
 After completion of the training intervention, overall 3MBL values trended higher (d=0.28; 
p=0.075). Additionally, the implementation of training was shown to improve PPO across both 
groups (∆BCa: 16w; p<0.001; ∆HC: 7w; p=0.020), which could have influenced 3MBL lactate 
levels. By improving muscular endurance through training, both BCa survivors and HC were able 
to continue exercise at higher workloads. This indicates both groups had more exercise time, 
allowing for greater accumulation of BL. Whether this improvement in PPO was a result of 
improved metabolic function or increased muscle fiber recruitment/size is unknown. Although 
group differences presented as a non-significant result, visual interpretation of the data reveals that 
the group differences demonstrated at baseline diminished largely due to increases in BCa survivor 
values. On average, BCa survivors improved more than 0.8mmol/L whereas HC were virtually 
unchanged with less than a 0.1mmol/L increase. This result potentially implies that, with a larger 
sample size, lactate production in BCa survivors may show improvements following combined 
exercise training, however further research is warranted to validate this pattern. Additionally, 
combined training interventions may aid in improving cancer-specific metabolic dysfunction, such 
as the Warburg Effect (Gentric et al., 2017), due to the improvements seen in BCa survivors but 
not within HC.   
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Highly Predictive Continuous RER Analysis 
Aim 1c 
 The third aim of this study was to approach RER as a continuous variable, analyzing the 
relationship of intensity, group, and training with RER values. By investigating the full duration 
of the test, RER measures may provide additional information as to how metabolic reliance shifts 
from aerobic to anaerobic pathways that may be obscured when examining fixed workloads. Due 
to the non-linear relationship of RER and intensity (Brooks et al., 2005), quadratic regression 
modeling produced the most accurate predictive models. Intensity2 served as the strongest 
predictor of RER (R2=0.987; p<0.001), which aligns with the theory that metabolic response and 
workload are closely related (Brooks et al., 2005). At baseline, the incorporation of group and the 
associated interaction terms into the predictive model had little impact, as BCa survivors and HC 
had comparable increases in RER as a function of intensity. Because the interaction of intensity2 
x group had no impact, there is no divergence or convergence of group-based RER data during a 
CPET. Similar to the fixed workloads approach, the continuous analysis of RER across increasing 
intensity differs from the results presented by Tosti et al. (2011). BCa survivors did not exhibit 
lowered CHO oxidation rates and elevated fat oxidation rates throughout the duration of the CPET, 
perhaps implicating less metabolic dysfunction than predicted. Much like aim 1a, contrasts to 
previous literature could be due to the non-steady state nature of a CPET, but may also be due to 
reduced metabolic efficiency in HC.    
Aim 2c 
 When incorporating training into the predictive model, training further improved the 
model’s predictivity by ∆R2=0.007 (R2=0.994; p<0.001). Aforementioned in aim 2a, all change 
scores for RER measures were positive, although non-significant. This increase in RER seen across 
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the duration of a CPET could explain the impact of training on the predictivity of the regression 
model. As RER levels tended to be higher following training, the model would need to adjust to 
accommodate larger increases in RER for a given increase in intensity. However, the overall 
increase in RER following training was unexpected. It is known that training can improve reliance 
on aerobic metabolism at higher intensities, lactate clearance, and H+ buffering, all of which would 
lower the amount of CO2 produced and reduce the overall RER value (Brooks et al., 2005; Péronnet 
& Aguilaniu, 2006; Stallknecht, Vissing, & Galbo, 1998). However, due to the potentially hindered 
CHO metabolism at baseline in BCa survivors (Edmonson, 1966), improvements in glycolytic 
oxidation may have driven the unexpected RER increase. Following analysis of training, group 
terms were incorporated into the model to investigate differences between BCa survivors and HC. 
Although group as a predictor was non-significant at pre-training, the quadratic intensity2 x group 
interaction term (p=0.019) became a significant addition to the model at post-training, just slightly 
improving the overall model fit (R2=0.994). However, this improvement to the model is minimal, 
and it cannot be argued that group is as strong of a predictor as intensity and training.  
 Notably, overall findings of aim 2c contradict those of aim 2a, although both approaches 
compared the same independent and dependent variables. By expanding the focus of RER from 
selected intensities at low (40% PPO), moderate (60% PPO), and high (70% PPO) ranges to a 
continuous analysis, both training and group appear to slightly impact metabolism. Because a 
ramp-protocol is a non-steady state approach, the use of a continuous analysis may have been more 
appropriate to analyze the overall metabolic response to a CPET as opposed to isolating individual 
intensities. Increases in RER following training across intensity could suggest greater glycolytic 
reliance in both BCa survivors and HC, perhaps through mechanisms such as improved insulin 
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sensitivity and/or training adaptations such as increased mitochondrial density, capillary density, 
and blood volume (Richter & Hargreaves, 2013; Rivera-Brown & Frontera, 2012).  
Exploratory Outcomes 
 An exploratory analysis was conducted following aims 1 through 3 to address the 
relationship between aerobic and anaerobic metabolism in BCa survivors and HC. It is known that 
VCO2 increases more rapidly than VO2 following VT, a phenomenon driven by lactic acid 
buffering and excessive CO2 production (Mezzani, 2017). Based on lowered lactate production at 
submaximal intensities (Evans et al., 2009; Tosti et al., 2011), it was assumed that perhaps the 
anaerobic pathways are hindered within BCa populations, causing a lowered overall lactate output. 
Upon investigation, it was confirmed that at sub-VT intensities, there was almost a 1-to-1 ratio of 
VCO2/VO2 in both BCa survivors and HC before and after training. This relationship was 
supported by average coefficients of determination equaling 0.98, suggesting a close to perfect 
linear fit. Beyond VT, the relationship of VCO2/VO2 increased at a rate range of 1.34-1.41, 
indicating that the participants were producing at least 34% more VCO2 than VO2. This increase 
in VCO2 confirms that participants were relying on increased anaerobic metabolic contributions to 
continue exercise. Interestingly, both groups post-VT slope values (and △Slope) decreased 
following training (BCa: d=0.39; HC: d=0.69), indicating that either excess VCO2 production was 
decreasing, and/or VO2 consumption was increasing. In this study, both VO2 peak (p=0.029) and 
PPO (p<0.001) increased across training, which may have influenced the decrease in post-VT 
slope values following training. In order to improve aerobic capacity and muscular fitness, 
metabolic adaptations must occur to enhance performance. These metabolic adaptations, in turn, 
could be reducing the excess VCO2 produced through improved reliance on aerobic metabolism 
at higher intensities, lactate clearance, and H+ buffering, as mentioned previously (Brooks et al., 
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2005; Péronnet & Aguilaniu, 2006; Stallknecht et al., 1998). There were small effects for group 
comparison at baseline (d=0.29) and post-training (d=0.20), which indicates that group may not 
have been as big of a factor compared to training.  
Conclusions 
 The use of exercise in cancer patients elicits positive mitigation of many treatment-related 
side effects, including the possibility of rescuing metabolic dysfunction, that may further aid in 
reducing fatigue and improve physical function. Although this study has demonstrated that 
combined exercise training may increase BL levels and possibly improve glycolytic function, the 
results presented here are preliminary and contradictory to steady-state exercise data. Because this 
is a preliminary, retrospective study, more research is required to promote investigation of 
metabolic function and the gaps that preside within the current literature. Due to the underpowered 
status of the statistics, increasing sample size and using a staged protocol should be the next steps 
to more accurately analyze these research questions. With enough evidence across different cancer 
populations, the inclusion of metabolic dysfunction as a side effect may merit consideration within 
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